Skip to main content
Addgene

pRM049 His-TEV-Cas9 triNLS 2C
(Plasmid #196245)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 196245 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pEC-K-MBP
  • Backbone manufacturer
    pET-based custom vector
  • Backbone size w/o insert (bp) 6400
  • Total vector size (bp) 9073
  • Modifications to backbone
    MBP removed
  • Vector type
    Bacterial Expression, CRISPR

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    Cas9
  • Alt name
    Cas9-2C-triNLS
  • Species
    Streptococcus pyogenes
  • Insert Size (bp)
    4102
  • Tags / Fusion Proteins
    • His6 (N terminal on backbone) (N terminal on insert)
    • HA (C terminal on insert)
    • SV40 (C terminal on insert)
    • Nucleoplasmin (C terminal on insert)
    • NLS (N terminal on insert)

Cloning Information

Resource Information

  • Supplemental Documents
  • A portion of this plasmid was derived from a plasmid made by
    pMJ806 was a gift from Jennifer Doudna (Addgene plasmid # 39312 ; http://n2t.net/addgene:39312 ; RRID:Addgene_39312)

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pRM049 His-TEV-Cas9 triNLS 2C was a gift from Ross Wilson (Addgene plasmid # 196245 ; http://n2t.net/addgene:196245 ; RRID:Addgene_196245)
  • For your References section:

    Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes. Foss DV, Muldoon JJ, Nguyen DN, Carr D, Sahu SU, Hunsinger JM, Wyman SK, Krishnappa N, Mendonsa R, Schanzer EV, Shy BR, Vykunta VS, Allain V, Li Z, Marson A, Eyquem J, Wilson RC. Nat Biomed Eng. 2023 May;7(5):647-660. doi: 10.1038/s41551-023-01032-2. Epub 2023 Apr 25. 10.1038/s41551-023-01032-2 PubMed 37147433